272 related articles for article (PubMed ID: 18394590)
1. PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.
Savić MM; Clayton T; Furtmüller R; Gavrilović I; Samardzić J; Savić S; Huck S; Sieghart W; Cook JM
Brain Res; 2008 May; 1208():150-9. PubMed ID: 18394590
[TBL] [Abstract][Full Text] [Related]
2. Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats?
Savić MM; Majumder S; Huang S; Edwankar RV; Furtmüller R; Joksimović S; Clayton T; Ramerstorfer J; Milinković MM; Roth BL; Sieghart W; Cook JM
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):376-86. PubMed ID: 20074611
[TBL] [Abstract][Full Text] [Related]
3. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
[TBL] [Abstract][Full Text] [Related]
4. The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats.
Savić MM; Milinković MM; Rallapalli S; Clayton T; Joksimović S; Van Linn M; Cook JM
Int J Neuropsychopharmacol; 2009 Oct; 12(9):1179-93. PubMed ID: 19265570
[TBL] [Abstract][Full Text] [Related]
5. Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?
Savić MM; Huang S; Furtmüller R; Clayton T; Huck S; Obradović DI; Ugresić ND; Sieghart W; Bokonjić DR; Cook JM
Neuropsychopharmacology; 2008 Jan; 33(2):332-9. PubMed ID: 17392731
[TBL] [Abstract][Full Text] [Related]
6. GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.
Atack JR
Curr Top Med Chem; 2011; 11(9):1203-14. PubMed ID: 21050171
[TBL] [Abstract][Full Text] [Related]
7. PWZ-029, an inverse agonist selective for α₅ GABAA receptors, improves object recognition, but not water-maze memory in normal and scopolamine-treated rats.
Milić M; Timić T; Joksimović S; Biawat P; Rallapalli S; Divljaković J; Radulović T; Cook JM; Savić MM
Behav Brain Res; 2013 Mar; 241():206-13. PubMed ID: 23261875
[TBL] [Abstract][Full Text] [Related]
8. An inverse agonist selective for alpha5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze.
Collinson N; Atack JR; Laughton P; Dawson GR; Stephens DN
Psychopharmacology (Berl); 2006 Nov; 188(4):619-28. PubMed ID: 16633803
[TBL] [Abstract][Full Text] [Related]
9. An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition.
Dawson GR; Maubach KA; Collinson N; Cobain M; Everitt BJ; MacLeod AM; Choudhury HI; McDonald LM; Pillai G; Rycroft W; Smith AJ; Sternfeld F; Tattersall FD; Wafford KA; Reynolds DS; Seabrook GR; Atack JR
J Pharmacol Exp Ther; 2006 Mar; 316(3):1335-45. PubMed ID: 16326923
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist.
Atack JR; Maubach KA; Wafford KA; O'Connor D; Rodrigues AD; Evans DC; Tattersall FD; Chambers MS; MacLeod AM; Eng WS; Ryan C; Hostetler E; Sanabria SM; Gibson RE; Krause S; Burns HD; Hargreaves RJ; Agrawal NG; McKernan RM; Murphy MG; Gingrich K; Dawson GR; Musson DG; Petty KJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):470-84. PubMed ID: 19704033
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure.
Fischer BD; Licata SC; Edwankar RV; Wang ZJ; Huang S; He X; Yu J; Zhou H; Johnson EM; Cook JM; Furtmüller R; Ramerstorfer J; Sieghart W; Roth BL; Majumder S; Rowlett JK
Neuropharmacology; 2010 Dec; 59(7-8):612-8. PubMed ID: 20727364
[TBL] [Abstract][Full Text] [Related]
13. Identification of amino acid residues responsible for the alpha5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABA(A) receptor.
Casula MA; Bromidge FA; Pillai GV; Wingrove PB; Martin K; Maubach K; Seabrook GR; Whiting PJ; Hadingham KL
J Neurochem; 2001 Apr; 77(2):445-51. PubMed ID: 11299307
[TBL] [Abstract][Full Text] [Related]
14. L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors.
Atack JR; Bayley PJ; Seabrook GR; Wafford KA; McKernan RM; Dawson GR
Neuropharmacology; 2006 Nov; 51(6):1023-9. PubMed ID: 17046030
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes.
Licata SC; Platt DM; Rüedi-Bettschen D; Atack JR; Dawson GR; Van Linn ML; Cook JM; Rowlett JK
Neuropharmacology; 2010 Feb; 58(2):357-64. PubMed ID: 19853619
[TBL] [Abstract][Full Text] [Related]
16. GABA/benzodiazepine receptors in the ventromedial hypothalamic nucleus regulate both anxiety and panic-related defensive responses in the elevated T-maze.
Bueno CH; Zangrossi H; Viana Mde B
Brain Res Bull; 2007 Sep; 74(1-3):134-41. PubMed ID: 17683799
[TBL] [Abstract][Full Text] [Related]
17. Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Behav Brain Res; 2005 Mar; 158(2):293-300. PubMed ID: 15698896
[TBL] [Abstract][Full Text] [Related]
18. Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effects.
Obradović ALj; Joksimović S; Poe MM; Ramerstorfer J; Varagic Z; Namjoshi O; Batinić B; Radulović T; Marković B; Roth BL; Sieghart W; Cook JM; Savić MM
Brain Res; 2014 Mar; 1554():36-48. PubMed ID: 24472579
[TBL] [Abstract][Full Text] [Related]
19. A Benzodiazepine Ligand with Improved GABA
Simeone X; Koniuszewski F; Müllegger M; Smetka A; Steudle F; Puthenkalam R; Ernst M; Scholze P
Mol Pharmacol; 2021 Jan; 99(1):39-48. PubMed ID: 33268553
[TBL] [Abstract][Full Text] [Related]
20. Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABA
Stamenić TT; Poe MM; Rehman S; Santrač A; Divović B; Scholze P; Ernst M; Cook JM; Savić MM
Eur J Pharmacol; 2016 Nov; 791():433-443. PubMed ID: 27639297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
